A closer look as some of the latest spirometers and pulmonary function testing (PFT) diagnostic devices on the market from coVita, FutureMed, MGC Diagnostics, and Vitalograph.

MGC Diagnostics Corp

Designed to provide comfort and performance, Platinum Elite Series body plethysmographs from MGC Diagnostics are state-of-the-art devices that seamlessly combine superior testing capabilities with unmatched space efficiency. Technologists appreciate its compact design, user-friendliness, and comprehensive diagnostics, while patients enjoy the spacious interior and generous foot room. (see image above)

Vitalograph Inc

The Vitalograph Compact is a respiratory diagnostic workstation with an integrated V-Core flowhead and Spirotrac 6 testing software, allowing you to focus on helping your patients achieve their best spirometry results. The Compact has a touchscreen interface, multiple inputs for peripheral devices, and facilitates respiratory muscle strength in one efficient solution. (top left image)

Vitalograph’s In2itive is a powerful V-Core spirometer that fits in the palm of your hand for accurate and connected testing, wherever it is needed. It has an easy-to-navigate interface and can store more than 10,000 tests. Its robust, detachable flowhead and large touch screen facilitate point-of-care spirometry that is compliant with ATS/ERS 2019 Technical Standards. (right image)

Available from Vitalograph, the tremoflo C-100 is a powerful, portable oscillometry testing solution. The device uses airwave oscillometry, which provides specific information about small airway function.  Testing with the tremoflo C-100 requires no forced maneuver, making it ideal for pediatric patients or anyone who might have difficulty performing an FVC blow. (lower left image)


coVita|Bedfont Scientific, leaders in breath analysis equipment, offer the FDA-cleared NObreath FeNO (fractional exhaled nitric oxide) monitor. The NObreath is a noninvasive, quick, and easy-to-perform breath test that is reimbursable, assists in asthma management, aids in prescribing medication, makes safer/monitored adjustments to medication, shows patient adherence to treatment, and aids in differentiating between allergic (eosinophilic) and nonallergic asthma.


Futuremed’s Discovery-2 is a diagnostic spirometer equipped with features that minimize risks of testing in an office or bedside. Testing is done with single-use antiviral and antibacterial filters, to reduce chance of cross-contamination within the device or in the examination space. All parts of Discovery-2, including the sensor, are easily disinfected, for optimal hygiene.